Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
[18F]PBR111
DRUG
2 trials
Sponsors
GlaxoSmithKline
, Prof. Daniele Zullino
Conditions
Dosimetry
Healthy
Multiple Sclerosis
Phase 2
[18F]PBR111 and Microglial Activation in Multiple Sclerosis
Terminated
NCT01428505
GlaxoSmithKline
Multiple Sclerosis
Start: 2011-07-31
End: 2013-03-31
Updated: 2016-02-08
Unknown Phase
Radiation Dosimetry of the 18 kDa Translocator Protein Ligand [18F]PBR111 in Humans
Completed
NCT06398392
Prof. Daniele Zullino
Dosimetry, Healthy
Start: 2024-06-24
End: 2024-07-30
Updated: 2025-09-16
Related Papers
Radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans
Nuclear Medicine and Biology
2025-03-31
1 citations